Arkema (AKE) Stock Overview
Manufactures and sells specialty materials in Europe, the United States, Canada, Mexico, China, Hong Kong, Taiwan, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
AKE Community Fair Values
Create NarrativeSee what 48 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Arkema S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €63.05 |
| 52 Week High | €67.05 |
| 52 Week Low | €48.30 |
| Beta | 0.96 |
| 1 Month Change | 1.78% |
| 3 Month Change | 12.69% |
| 1 Year Change | 2.85% |
| 3 Year Change | -25.28% |
| 5 Year Change | -41.40% |
| Change since IPO | 95.50% |
Recent News & Updates
Narrative Update • Jun 03
AKE: Prolonged Earnings And ROIC Headwinds Will Restrain Future Re Rating Potential
Arkema's updated analyst price target has shifted to €50.00, with analysts citing a tougher mid term earnings and return outlook across European chemicals, fading near term benefits from the Middle East conflict, and mixed rating changes that reflect differing views on the company's long run profitability and P/E potential. Analyst Commentary Recent research on Arkema points to a more cautious tone, with the updated €50.00 price target sitting against a backdrop of several bearish revisions and a few more supportive views.
Narrative Update • May 20
AKE: Battery Materials Expansion And Mixed Ratings Will Shape Balanced Future Prospects
Arkema's analyst price target nudged higher by about €2 to €63.88 as analysts updated their models to reflect revised assumptions for revenue growth, profit margins, discount rates and future P/E multiples following a mix of recent upgrades, downgrades and modest target increases. Analyst Commentary Recent research on Arkema presents a mixed picture, with some analysts lifting price targets or ratings and others turning more cautious.Analysis Article • May 18
Some May Be Optimistic About Arkema's (EPA:AKE) Earnings
Soft earnings didn't appear to concern Arkema S.A.'s ( EPA:AKE ) shareholders over the last week. We think that the...Recent updates
Narrative Update • Jun 03
AKE: Prolonged Earnings And ROIC Headwinds Will Restrain Future Re Rating Potential
Arkema's updated analyst price target has shifted to €50.00, with analysts citing a tougher mid term earnings and return outlook across European chemicals, fading near term benefits from the Middle East conflict, and mixed rating changes that reflect differing views on the company's long run profitability and P/E potential. Analyst Commentary Recent research on Arkema points to a more cautious tone, with the updated €50.00 price target sitting against a backdrop of several bearish revisions and a few more supportive views.Narrative Update • May 20
AKE: Battery Materials Expansion And Mixed Ratings Will Shape Balanced Future Prospects
Arkema's analyst price target nudged higher by about €2 to €63.88 as analysts updated their models to reflect revised assumptions for revenue growth, profit margins, discount rates and future P/E multiples following a mix of recent upgrades, downgrades and modest target increases. Analyst Commentary Recent research on Arkema presents a mixed picture, with some analysts lifting price targets or ratings and others turning more cautious.Analysis Article • May 18
Some May Be Optimistic About Arkema's (EPA:AKE) Earnings
Soft earnings didn't appear to concern Arkema S.A.'s ( EPA:AKE ) shareholders over the last week. We think that the...
Narrative Update • Apr 30
AKE: Battery Materials Expansion Will Support Future Rerating Potential
Arkema's analyst fair value estimate has moved slightly higher to about €81.56, reflecting analysts' updated assumptions on revenue growth, profit margins, and future P/E in light of recent upgrades, downgrades, and modest price target increases from several banks. Analyst Commentary Recent Street research on Arkema is mixed, but there is a clear cluster of more constructive calls that help frame how supportive analysts currently see the risk and reward around the stock.Narrative Update • Apr 15
AKE: Battery Expansion And Margin Execution Will Constrain Future Re Rating Potential
Arkema's fair value estimate has shifted from €44.00 to €50.00 as analysts factor in updated assumptions on revenue growth, profit margins and future P/E multiples, in line with a recent series of higher price targets and rating changes across major research firms. Analyst Commentary Recent Street research on Arkema presents a mixed picture, with several higher price targets sitting alongside at least one downgrade and more restrained views on upside.Narrative Update • Apr 01
AKE: Battery Capacity Push Will Face Execution Risk And Uncertain Earnings Trajectory
Analysts have nudged Arkema's average price target higher to around €60 to €65, citing recent target increases from several banks and mixed rating changes that reflect a more balanced view on growth, margins, and a higher assumed future P/E multiple. Analyst Commentary Recent research has given Arkema a more mixed backdrop, with some banks lifting price targets while others turn more cautious on the shares, despite keeping targets within a relatively tight €60 to €65 range.Narrative Update • Mar 18
AKE: Battery Materials Expansion And Mixed Ratings Will Shape Future Rerating
Arkema's analyst price target has edged up by €0.13 to €61.88, reflecting a blend of higher fair value P/E assumptions and mixed rating actions from analysts who have recently adjusted targets between €60 and €65. Analyst Commentary Bullish Takeaways Bullish analysts are comfortable assigning price targets in the €62 to €65 range, which supports the current blended target of €61.88 and signals confidence that Arkema can justify a slightly higher P/E than previously assumed.Narrative Update • Mar 04
AKE: Battery Materials Expansion And Decarbonization Efforts Will Support Future Rerating
Our analyst price target for Arkema shifts from €65.06 to €61.88 as analysts factor in recent downgrades and lower external price targets, along with updated assumptions for revenue growth, profit margins and future P/E multiples. Analyst Commentary Recent Street research on Arkema has been mixed, with both upgrades and downgrades sitting alongside reduced price targets.Narrative Update • Feb 17
AKE: Battery Materials And Specialty Polymers Will Support Re Rating
Arkema's analyst price target has shifted from €85.00 to €80.00, as analysts factor in slightly softer assumptions on revenue growth, profit margins and future P/E, even as recent research updates include both an upgrade and a separate €5 adjustment to targets. Analyst Commentary Recent research on Arkema sends a mixed but broadly constructive signal, with the latest changes in price targets and ratings pointing to a more nuanced view of the company’s risk and reward profile.Analysis Article • Feb 13
After Leaping 26% Arkema S.A. (EPA:AKE) Shares Are Not Flying Under The Radar
The Arkema S.A. ( EPA:AKE ) share price has done very well over the last month, posting an excellent gain of 26%. Not...Narrative Update • Feb 03
AKE: Battery Expansion Will Face Tougher Sector Backdrop And Execution Risk
Analysts have trimmed their price target on Arkema by €5, reflecting softer revenue growth assumptions, a slightly lower future P/E multiple, and sector headwinds highlighted in recent research, while keeping fair value broadly unchanged. Analyst Commentary Recent research points to a more cautious tone around Arkema, with pricing assumptions and sector views putting some pressure on sentiment.Narrative Update • Jan 20
AKE: Battery Materials Expansion Will Face Tougher Sector Backdrop And Execution Risk
Narrative update Analysts have trimmed their price target on Arkema by €3 to €44, reflecting a lower fair value estimate along with updated views on revenue growth, margins and a reduced future P/E multiple, following recent cautious research on European chemicals and ingredients groups. Analyst Commentary Street research on Arkema has turned more cautious, with bearish analysts trimming price targets and flagging risks around growth visibility and valuation.Narrative Update • Jan 06
AKE: Battery Materials Push Will Support Re Rating Despite Sector Downgrade
Analysts have trimmed their fair value estimate for Arkema to €85 from €95. This reflects lower assumed revenue growth, a slightly softer profit margin profile, a higher discount rate and more conservative future P/E expectations following recent cuts to Street price targets and a sector downgrade.Narrative Update • Dec 21
AKE: Battery Materials Push Will Confront Tougher Sector Backdrop Ahead
The analyst fair value estimate for Arkema has been reduced from EUR 56 to EUR 47 as analysts factor in a higher discount rate, weaker revenue growth expectations, softer profit margins, and a sector wide shift toward more favored industrial gases and specialty distributors. Analyst Commentary Recent Street research reflects a more cautious stance on Arkema, with several bearish analysts trimming price targets and, in at least one case, reducing their rating.Narrative Update • Dec 07
AKE: Sustainability And Decarbonization Investments Will Drive Future Rerating Despite Recent Downgrade
Arkema's analyst price target has been trimmed by about EUR 1 to EUR 65.06 as analysts factor in slightly softer long term growth and margin expectations, alongside a wave of recent price target cuts and a fresh Underweight rating from the Street. Analyst Commentary Recent Street research presents a mixed picture for Arkema, with several price target cuts but divergent views on the company’s medium term execution and earnings power.Narrative Update • Nov 23
AKE: Recent Downgrade Will Be Offset By Sustainability Actions And Emissions Reductions
Analysts have lowered the fair value estimate for Arkema from €70.63 to €66.06, citing cautious sector sentiment and a series of reduced price targets across the chemical industry. Analyst Commentary Analysts continue to reassess Arkema's prospects in response to both company-specific and broader sector developments.Analysis Article • Nov 16
There May Be Reason For Hope In Arkema's (EPA:AKE) Disappointing Earnings
Arkema S.A.'s ( EPA:AKE ) stock was strong despite it releasing a soft earnings report last week. We think that...Analysis Article • Nov 12
Arkema S.A. (EPA:AKE) Just Reported, And Analysts Assigned A €66.94 Price Target
Investors in Arkema S.A. ( EPA:AKE ) had a good week, as its shares rose 6.6% to close at €52.60 following the release...Narrative Update • Nov 06
AKE: Operational Improvements And Sustainability Efforts Will Drive Future Upside
The consensus analyst price target for Arkema has been reduced notably in recent updates, with targets now ranging from EUR 55 to EUR 80. Analysts cite cautious expectations for revenue growth and refining profit margin assumptions as reasons for the adjustment.Narrative Update • Oct 23
Analysts Revise Arkema Price Target Lower Amid Cautious Optimism and Recent Sustainability Initiatives
Arkema's analyst price target has been revised downward from €72.75 to €70.63. This change reflects recent analyst adjustments driven by lower growth and profit expectations.Narrative Update • Oct 09
New Capacity And R&D Focus Will Accelerate Renewable Transition
Arkema's analyst price target has been revised downward from €76.06 to €72.75. This change reflects analysts' expectations for slower revenue growth and a higher discount rate, even though profit margins have seen slight improvement.Narrative Update • Sep 25
New Capacity And R&D Focus Will Accelerate Renewable Transition
Analysts have trimmed Arkema’s price target to €76.06, reflecting heightened caution around 2025 guidance cuts, persistent margin pressure, and weaker end-market demand, despite some confidence in the company’s long-term positioning. Analyst Commentary Bearish analysts cite increased risk of significant 2025 guidance cuts, particularly ahead of Q2 results.Analysis Article • Aug 27
Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?
While Arkema S.A. ( EPA:AKE ) might not have the largest market cap around , it received a lot of attention from a...Analysis Article • Aug 06
Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Arkema S.A. ( EPA:AKE ) shareholders are probably feeling a little disappointed, since its shares fell 6.5% to €58.65...Analysis Article • Jul 27
These 4 Measures Indicate That Arkema (EPA:AKE) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analysis Article • Jul 05
Potential Upside For Arkema S.A. (EPA:AKE) Not Without Risk
There wouldn't be many who think Arkema S.A.'s ( EPA:AKE ) price-to-earnings (or "P/E") ratio of 15.1x is worth a...
New Narrative • Dec 05
Specialty Materials And Renewable Energy Initiatives Ignite Earnings Growth And Margin Expansion
Strategic projects and acquisitions aim to enhance Arkema's earnings growth and stability, leveraging mega trends in energy and healthcare.Shareholder Returns
| AKE | FR Chemicals | FR Market | |
|---|---|---|---|
| 7D | 5.7% | -1.4% | -1.4% |
| 1Y | 2.9% | -2.1% | 0.3% |
Return vs Industry: AKE exceeded the French Chemicals industry which returned -2.8% over the past year.
Return vs Market: AKE exceeded the French Market which returned 1.8% over the past year.
Price Volatility
| AKE volatility | |
|---|---|
| AKE Average Weekly Movement | 5.1% |
| Chemicals Industry Average Movement | 6.9% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in FR Market | 11.2% |
| 10% least volatile stocks in FR Market | 2.8% |
Stable Share Price: AKE has not had significant price volatility in the past 3 months compared to the French market.
Volatility Over Time: AKE's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 20,700 | Thierry Le Henaff | www.arkema.com |
Arkema S.A., together with its subsidiaries, manufactures and sells specialty materials in Europe, the United States, Canada, Mexico, China, Hong Kong, Taiwan, and internationally. It operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The company provides solutions for construction, renovation of buildings, and DIY; high performance adhesives for durable goods, and adhesive solutions for packaging and non-woven; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
Arkema S.A. Fundamentals Summary
| AKE fundamental statistics | |
|---|---|
| Market cap | €4.77b |
| Earnings (TTM) | €17.00m |
| Revenue (TTM) | €8.87b |
280.6x
P/E Ratio0.5x
P/S RatioIs AKE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AKE income statement (TTM) | |
|---|---|
| Revenue | €8.87b |
| Cost of Revenue | €7.31b |
| Gross Profit | €1.56b |
| Other Expenses | €1.54b |
| Earnings | €17.00m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Jul 30, 2026
| Earnings per share (EPS) | 0.22 |
| Gross Margin | 17.55% |
| Net Profit Margin | 0.19% |
| Debt/Equity Ratio | 59.9% |
How did AKE perform over the long term?
See historical performance and comparisonDividends
5.7%
Current Dividend Yield1,599%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/03 13:31 |
| End of Day Share Price | 2026/06/03 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Arkema S.A. is covered by 31 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gaurav Jain | Barclays |
| Katie Richards | Barclays |
| James Stewart | Barclays |